EMAIL THIS PAGE TO A FRIEND

Voprosy virusologii

[Evolution of influenza A(H3N2) virus from 2007 to 2012].


PMID 24772643

Abstract

The results of the genetic studies of influenza viruses make it possible to understand their evolution and recommendations for vaccine strains content. In this work, the data of complete sequence of the HA, NA, and M2-protein for 34 strains of influenza A(H3N2) virus circulating in Russia during 2007-2012 are presented. The influenza strains were isolated in Ivanovsky Institute of Virology, Moscow, and some collaborating Russian centers. The results of the phylogenetic analysis showed the differences among strains, which were observed during the analyzed period; the evolution had direction from A/Brisbane/10/2007 to A/Perth/16/2009 and A/ Victoria/208/2009. Hemagglutinin of the influenza A(H3N2) virus strains had differences between strains of last two seasons and strains circulating before, in the antigenic sites A, B, D, and, to a lesser extent, C, and E. In the neuraminidase gene the mutations responsible for the resistance to oseltamivir (E119V, R292K, N294S) and zanamivir (Q136K) were not found. All isolates carry the S31N mutation in the M2 gene responsible for resistance to amantadine.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

N7271 α(2→3) Neuraminidase from Streptococcus pneumoniae, buffered aqueous solution
N5521 α(2→3,6) Neuraminidase from Clostridium perfringens (C. welchii), recombinant, expressed in E. coli, buffered aqueous solution, ≥250 units/mg protein
N3786
α(2→3,6,8,9) Neuraminidase from Arthrobacter ureafaciens, Proteomics Grade, suitable for MALDI-TOF MS
N8271 α(2→3,6,8,9) Neuraminidase from Arthrobacter ureafaciens, recombinant, expressed in E. coli, buffered aqueous solution
N5254 Neuraminidase Agarose from Clostridium perfringens (C. welchii), Type VI-A, ammonium sulfate suspension
N2876
Neuraminidase from Clostridium perfringens (C. welchii), Suitable for manufacturing of diagnostic kits and reagents, Type V, lyophilized powder
N3001
Neuraminidase from Clostridium perfringens (C. welchii), Type VI, lyophilized powder, 6-10 units/mg protein (using 4MU-NANA), 2-5 units/mg protein (mucin)
N5631
Neuraminidase from Clostridium perfringens (C. welchii), Type VIII, lyophilized powder, 10-20 units/mg protein (using 4MU-NANA), 3.5-8.0 units/mg protein (mucin)
N2133
Neuraminidase from Clostridium perfringens (C. welchii), Type X, lyophilized powder, ≥50 units/mg protein (using 4MU-NANA)
N7885
Neuraminidase from Vibrio cholerae, Type III, buffered aqueous solution, 0.2 μm filtered, 1-5 units/mg protein (Lowry, using NAN-lactose)
N6514
Neuraminidase from Vibrio cholerae, Type II, buffered aqueous solution, 8-24 units/mg protein (Lowry, using NAN-lactose)
72197
Neuraminidase from Vibrio cholerae, ≥1.5 U/mL, specific activity ≥1.5 U/mg protein